MCID: MXL008
MIFTS: 25

Maxillary Sinus Cancer

Categories: Cancer diseases, Respiratory diseases

Aliases & Classifications for Maxillary Sinus Cancer

MalaCards integrated aliases for Maxillary Sinus Cancer:

Name: Maxillary Sinus Cancer 12 15
Malignant Tumor of the Maxillary Sinus 12
Malignant Neoplasm of Antrum 12
Maxillary Sinus Neoplasms 74
Maxillary Sinus Carcinoma 74
Cancer of Maxillary Sinus 74

Classifications:



External Ids:

Disease Ontology 12 DOID:1357
ICD9CM 36 160.2
NCIt 51 C3540 C9332
SNOMED-CT 69 93889000
ICD10 34 C31.0

Summaries for Maxillary Sinus Cancer

MalaCards based summary : Maxillary Sinus Cancer, also known as malignant tumor of the maxillary sinus, is related to pyloric antrum cancer and sinus cancer, and has symptoms including pain and rhinorrhea. An important gene associated with Maxillary Sinus Cancer is MALL (Mal, T Cell Differentiation Protein Like). Related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Related Diseases for Maxillary Sinus Cancer

Diseases related to Maxillary Sinus Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 pyloric antrum cancer 11.3
2 sinus cancer 10.7
3 neuroendocrine carcinoma 9.9
4 adenosquamous carcinoma 9.9
5 paranasal sinus cancer 8.6 LDHB MALL MAML2 TAPBP UHMK1

Graphical network of the top 20 diseases related to Maxillary Sinus Cancer:



Diseases related to Maxillary Sinus Cancer

Symptoms & Phenotypes for Maxillary Sinus Cancer

UMLS symptoms related to Maxillary Sinus Cancer:


pain, rhinorrhea

GenomeRNAi Phenotypes related to Maxillary Sinus Cancer according to GeneCards Suite gene sharing:

27 (show all 24)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-105 10.03 LDHB
2 Increased shRNA abundance (Z-score > 2) GR00366-A-11 10.03 PPP1CB
3 Increased shRNA abundance (Z-score > 2) GR00366-A-120 10.03 LDHB
4 Increased shRNA abundance (Z-score > 2) GR00366-A-132 10.03 LDHB
5 Increased shRNA abundance (Z-score > 2) GR00366-A-138 10.03 UHMK1
6 Increased shRNA abundance (Z-score > 2) GR00366-A-159 10.03 PPP1CB
7 Increased shRNA abundance (Z-score > 2) GR00366-A-163 10.03 UHMK1
8 Increased shRNA abundance (Z-score > 2) GR00366-A-177 10.03 PPP1CB
9 Increased shRNA abundance (Z-score > 2) GR00366-A-189 10.03 LDHB
10 Increased shRNA abundance (Z-score > 2) GR00366-A-192 10.03 UHMK1
11 Increased shRNA abundance (Z-score > 2) GR00366-A-197 10.03 LDHB
12 Increased shRNA abundance (Z-score > 2) GR00366-A-2 10.03 UHMK1
13 Increased shRNA abundance (Z-score > 2) GR00366-A-210 10.03 PPP1CB
14 Increased shRNA abundance (Z-score > 2) GR00366-A-214 10.03 PPP1CB
15 Increased shRNA abundance (Z-score > 2) GR00366-A-23 10.03 LDHB UHMK1
16 Increased shRNA abundance (Z-score > 2) GR00366-A-25 10.03 UHMK1
17 Increased shRNA abundance (Z-score > 2) GR00366-A-39 10.03 LDHB PPP1CB
18 Increased shRNA abundance (Z-score > 2) GR00366-A-43 10.03 UHMK1
19 Increased shRNA abundance (Z-score > 2) GR00366-A-57 10.03 LDHB PPP1CB
20 Increased shRNA abundance (Z-score > 2) GR00366-A-79 10.03 LDHB
21 Increased shRNA abundance (Z-score > 2) GR00366-A-81 10.03 PPP1CB
22 Increased shRNA abundance (Z-score > 2) GR00366-A-88 10.03 UHMK1
23 Downregulation of NF-kappaB pathway after LMP1 stimulation GR00199-A-1 9.16 PPP1CB UHMK1
24 Downregulation of NF-kappaB pathway after TNFalpha stimulation GR00199-A-2 8.96 PPP1CB UHMK1

Drugs & Therapeutics for Maxillary Sinus Cancer

Search Clinical Trials , NIH Clinical Center for Maxillary Sinus Cancer

Genetic Tests for Maxillary Sinus Cancer

Anatomical Context for Maxillary Sinus Cancer

Publications for Maxillary Sinus Cancer

Articles related to Maxillary Sinus Cancer:

(show all 36)
# Title Authors Year
1
Definitive Radiation Therapy Versus Postoperative Radiation Therapy for Patients With Maxillary Sinus Cancer Invading the Upper Jaw. ( 30882578 )
2019
2
Therapeutic efficacy of regional and systemic chemotherapy in advanced maxillary sinus cancer. ( 30924582 )
2019
3
Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose-finding phase. ( 29130565 )
2018
4
Recurrent maxillary sinus cancer with only adrenal metastasis. ( 29181177 )
2017
5
Treatment outcomes of intensity-modulated radiotherapy versus 3D conformal radiotherapy for patients with maxillary sinus cancer in the postoperative setting. ( 25538027 )
2016
6
SUVmax on FDG-PET is a predictor of prognosis in patients with maxillary sinus cancer. ( 26920841 )
2016
7
Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC). ( 25332419 )
2015
8
Functional evaluation of a CAD/CAM prosthesis for immediate defect repair after total maxillectomy: a case series of 18 patients with maxillary sinus cancer. ( 25345998 )
2015
9
Effect of local extension sites on survival in locally advanced maxillary sinus cancer. ( 23996685 )
2014
10
Quality of life in advanced maxillary sinus cancer after radical versus conservative maxillectomy. ( 23851810 )
2013
11
Neoadjuvant intra-arterial chemotherapy combined with radiotherapy and surgery in patients with advanced maxillary sinus cancer. ( 24137556 )
2013
12
Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer. ( 24196792 )
2013
13
Treatment outcomes between concurrent chemoradiotherapy and combination of surgery, radiotherapy, and/or chemotherapy in stage III and IV maxillary sinus cancer: multi-institutional retrospective analysis. ( 21945430 )
2012
14
The Role of EGFR and HER2- Activating Mutations in Maxillary Sinus Cancer. ( 23118824 )
2012
15
Intravitreal bevacizumab for delayed radiation maculopathy and papillopathy after irradiation for maxillary sinus cancer. ( 21966189 )
2011
16
Advanced maxillary sinus cancer treated with concurrent chemoradiotherapy with intra-arterial cisplatin/docetaxel and oral s-1: own experience and literature review. ( 22114575 )
2011
17
A colliding maxillary sinus cancer of adenosquamous carcinoma and small cell neuroendocrine carcinoma--a case report with EGFR copy number analysis. ( 20961443 )
2010
18
Detection and prediction of local recurrence of maxillary sinus cancer using F-18 FDG PET/CT. ( 19883988 )
2010
19
Vascular supply with angio-CT for superselective intra-arterial chemotherapy in advanced maxillary sinus cancer. ( 20139264 )
2010
20
Treatment outcome of maxillary sinus cancer. ( 21139915 )
2009
21
Superselective intra-arterial chemotherapy for advanced maxillary sinus cancer: an evaluation of arterial perfusion with computed tomographic arteriography and of tumor response. ( 18520544 )
2008
22
Postoperative radiotherapy for maxillary sinus cancer: long-term outcomes and toxicities of treatment. ( 17543999 )
2007
23
State of mastication affects quality of life in patients with maxillary sinus cancer. ( 12671436 )
2003
24
Factors affecting survival in maxillary sinus cancer. ( 12966476 )
2003
25
Influence of postsurgical residual tumor volume on local control in radiotherapy for maxillary sinus cancer. ( 11450993 )
2001
26
The dynamic observation of serum level of SIL-2R and TNF in maxillary sinus cancer. ( 12899331 )
2001
27
Maxillary sinus cancer and metastatic compression of the cauda equina: report of two cases. ( 18350708 )
2001
28
[The preliminary research of maxillary sinus cancer on oncogene level]. ( 12541828 )
2001
29
Induction of apoptosis in maxillary sinus cancer cells by 5-fluorouracil, vitamin A and radiation (FAR) therapy. ( 10337531 )
1999
30
Intra--arterial chemotherapy in the management of advanced maxillary sinus cancer. ( 8258472 )
1993
31
Potential improvement of three dimension treatment planning and proton therapy in the outcome of maxillary sinus cancer. ( 1310965 )
1992
32
A case-control study of past history of nasal diseases and maxillary sinus cancer in Hokkaido, Japan. ( 3345533 )
1988
33
Slow-release local chemotherapeutic regimen for maxillary sinus cancer. ( 2429645 )
1986
34
Maxillary sinus cancer: a study of 33 cases. ( 3918151 )
1985
35
Cancer of the paranasal sinuses with particular reference to maxillary sinus cancer. ( 6663664 )
1983
36
Epidemiologic patterns of frontal and maxillary sinus cancer. ( 7144401 )
1982

Variations for Maxillary Sinus Cancer

Expression for Maxillary Sinus Cancer

Search GEO for disease gene expression data for Maxillary Sinus Cancer.

Pathways for Maxillary Sinus Cancer

GO Terms for Maxillary Sinus Cancer

Cellular components related to Maxillary Sinus Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 membrane raft GO:0045121 8.62 LDHB MALL

Biological processes related to Maxillary Sinus Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 carbohydrate metabolic process GO:0005975 8.62 LDHB PPP1CB

Sources for Maxillary Sinus Cancer

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....